← Eichor
Condition: Lymphoproliferative Syndrome Autoimmune Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lymphoproliferative Syndrome Autoimmune

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Belimumab After Rituximab in Resistant Primary Juvenile SS
Phase 4 · 1 location(s) · Peking Union Medical College Hospital · NCT06410833Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06339177AutoInflammatory Disease Alliance Registry (AIDA)
Phase N/A · 112 location(s) · University of Siena · NCT05200715Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Charact
Phase N/A · 1 location(s) · Medical University Innsbruck · NCT04538937Vasculitis Pregnancy Registry
Phase N/A · 1 location(s) · University of Pennsylvania · NCT02593565Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Phase 1 · 5 location(s) · Tr1X, Inc. · NCT06462365Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00001350Rheumatology Patient Registry and Biorepository
Phase N/A · 1 location(s) · Yale University · NCT04402086Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT05127980Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04902807Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT07065747A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
Phase 3 · 15 location(s) · AstraZeneca · NCT06512883National Longitudinal Cohort of Hematological Diseases
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04645199VCRC Tissue Repository
Phase N/A · 8 location(s) · University of Pennsylvania · NCT02967068Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06781437IVIG vs SCIG in CIDP
Phase 1 · 1 location(s) · Rutgers, The State University of New Jersey · NCT05584631eGPA and Local Inflammation Within the Ear, Nose and Throat Area
Phase N/A · 1 location(s) · University Medical Center Groningen · NCT06298448EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07077304The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangii
NA · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07275190Cardiovascular Risk in Children With Chronic Conditions Study
Phase N/A · 3 location(s) · Semmelweis University · NCT07086989Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Phase N/A · 1 location(s) · Paul Szabolcs · NCT04528355Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Phase N/A · 10 location(s) · Peter Merkel · NCT03004326Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04339777One-Time DNA Study for Vasculitis
Phase N/A · 14 location(s) · University of Pennsylvania · NCT01241305National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Phase N/A · 13 location(s) · University of Pennsylvania · NCT00315380A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （
Phase 2/Phase 3 · 2 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT05979051Ocular Manifestations of Granulomatosis With Polyangiitis.
Phase N/A · 1 location(s) · Military Institute od Medicine National Research Institute · NCT07664709Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoprolife
Phase 2 · 3 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06730126Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Phase 2 · 1 location(s) · Paul Szabolcs · NCT01962415
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.